Navigation Links
Breast cancer risk varies among different progestins used in hormone replacement therapy
Date:8/10/2010

COLUMBIA, Mo. Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.

"Synthetic progestins have different biological effects, due to differences in their structure, stability and how they interact in the body," said Salman Hyder, the Zalk Endowed Professor in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center. "Clinical use of progestins requires caution. These powerful steroids should only be prescribed when a person has no latent, or dormant, cancer and does not have a family history of cancer. However, it is difficult to diagnose latent tumor cells in women since there are no symptoms."

In the study, researchers compared the effects of four clinically relevant progestins on breast cancer tumors in an animal model. The progestins used in the study were the synthetic progestin medroxporgresterone acetate (MPA), norgesterel (N-EL), norethindrone (N-ONE) and megestrol acetate (MGA). In the United States, most women on hormone replacement therapy are treated with MPA, the progestin in Prempro, Hyder said.

"Although previous studies using an animal model for breast cancer found that MPA functions as a tumor promoter, this study show that N-EL and N-One, when administrated using the same protocol as used for MPA, strongly inhibited tumor development," Hyder said. "Thus progestins seem to have tumor-stage specific effects, which determine whether these will function as tumor promoters or tumor
'/>"/>

Contact: Steven Adams
adamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... NutraScience Labs , a ... services, joined over 200 other Long Island-based corporations as participants in the 10th ... at Jones Beach State Park in Wantagh, New York. , According to Mindy ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... complete with full examination now offered by the world renowned Beverly Hills ... aesthetic facial appearance through cosmetic surgery techniques helps individuals to achieve an outer ...
(Date:8/4/2015)... ... , ... Montclair State University and Atlantic Health System have launched a new ... Jersey, which starting this Fall will help prepare those entering this burgeoning, hybrid field. ... System, one of the largest health care organizations in New Jersey, to design the ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... homes and other long-term care facilities, today announced details of the Advanced level ... homes and centers. , Providigm’s QAPI Accreditation program , introduced in 2013, ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... at unique artistic expressions from a diverse group of exceptionally talented female artists. ... Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. Curated ...
Breaking Medicine News(10 mins):Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 2Health News:Nursing Homes Achieving New Advanced Accreditation See Improved Measures of Quality, Better Occupancy Rates 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4
... Wound Care,Innovations, LLC, a subsidiary of Wound ... the 510k clearance of a new wound,management product ... new addition to our product line (patent pending) ... (PSGAG) and will initially be available in gel ...
... Cord Blood,America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on,bringing the life saving potential of ... that a letter to shareholders from CEO Matthew,Schissler ... letter explains,some of the positive scientific and economic ...
... Corgenix Medical Corporation,(OTC Bulletin Board: CONX), a ... sales of $2,001,896 for the first fiscal,quarter ended ... quarter,ended September 30, 2007, a decrease of 4.9%. ... over the same period,in the prior fiscal year., ...
... China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- China,Information Security ... Information,Security," "CIST" or the "Company"), a leading ... Information,Systems ("GIS") solutions provider to public security ... for 2009., China Information Technology has ...
... people choose to get representation when they apply for SSDI, a ... ... Belleville, IL (Vocus) November 13, 2008 -– Difficult decisions ... and one of the most important is how to begin the ...
... Nov. 13 TheraQuest Biosciences, Inc. a,development ... the U.S.,Food and Drug Administration (FDA) has ... TQ-1015, its abuse deterrent extended release,strong opioid. ... abuse deterrent technology., Najib Babul, PharmD, ...
Cached Medicine News:Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 2Health News:Wound Management Technologies, Inc. Announces FDA Clearance of 510k 3Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 2Health News:Cord Blood America Posts Letter to Shareholders: New Administration's Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders 3Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Corgenix Reports Financial Results for First Quarter of Fiscal 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 2Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 3Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 4Health News:China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 2Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 3Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 4Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 5Health News:Getting Your Social Security Disability Benefits Can Be Easier With A Professional On Your Side 6Health News:TheraQuest's IND for Abuse Deterrent Strong Opioid (TQ-1015) Accepted by FDA 2
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 /PRNewswire/ ... announced the addition of Jain PharmaBiotech,s new ... Markets, and Companies" to their offering. ... transdermal drug delivery - an approach used ... therapeutic use as an alternative to oral,intravascular, ...
(Date:8/4/2015)... York , August 4, 2015 ... titled " Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, ... Others) - Global Industry Analysis, Size, Volume, Share, Growth, ... According to a new market report published by Transparency ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ...
(Date:8/4/2015)... Organovo Holdings, Inc. (NYSE MKT: ONVO; ... scientific and medical breakthroughs using 3D bioprinting technology, ... Paul Gallant as its General Manager of ... Gallant has more than 20 years of management ... most recently serving as chief operating officer for ...
Breaking Medicine Technology:Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3
... variety of colors and classic shapes, ... designed with elegant jewel detail. With ... that are made from the same ... our fine timepieces, Timex branded frames ...
... captures the whimsy, charm and cutting edge ... design is inspired by Cynthia Rowley's creativity, ... from the Kenmark Group and B Robinson ... features eight optical and four sunwear designs ...
... collection offers a broad and definitive line ... value-minded consumer. The core line is a ... age and price sensitivity. The common theme ... high quality craftsmanship and a competitive price-versus-value ...
... The new Eyewear ... lifestyle proposition, encompassing elegance, ... well as a dedication ... Mirroring key attributes of ...
Medicine Products: